Literature DB >> 23358498

Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.

Song-Ho Chong1, Janghyun Yim, Sihyun Ham.   

Abstract

Alzheimer's disease is a neurodegenerative disorder characterized by progressive deposition of amyloid-beta (Aβ) peptides in brain parenchyma and cerebral blood vessels. Several pathogenic familial mutations of Aβ peptides have been identified that exhibit enhanced neurotoxicity and aggregative ability. However, knowledge of the structural characteristics of those Aβ mutants is still limited. Here, we report multiple all-atom molecular dynamics simulations of the wild-type 42-residue Aβ peptide (Aβ42) and its Flemish (A21G), Arctic (E22G), Dutch (E22Q), Italian (E22K), and Iowa (D23N) familial mutants in explicit water. After validating our simulations by comparison with available experimental data, we examined common/different features in the secondary and tertiary structures of the wild-type and five familial mutants of Aβ42. We found that Aβ42 peptides display quite heterogeneous secondary and tertiary structure ensembles. Such structural heterogeneity in the monomeric state would facilitate interconversions between various secondary structures during the formation of a β-sheet-rich amyloid fibril, and may also serve as a structural basis of the amyloid polymorphism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358498     DOI: 10.1039/c2mb25457c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  8 in total

1.  Structure-based inhibitors of amyloid beta core suggest a common interface with tau.

Authors:  Sarah L Griner; Paul Seidler; Jeannette Bowler; Kevin A Murray; Tianxiao Peter Yang; Shruti Sahay; Michael R Sawaya; Duilio Cascio; Jose A Rodriguez; Stephan Philipp; Justyna Sosna; Charles G Glabe; Tamir Gonen; David S Eisenberg
Journal:  Elife       Date:  2019-10-15       Impact factor: 8.140

2.  Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β40 and Amyloid-β42.

Authors:  Bappaditya Chandra; Venus Singh Mithu; Debanjan Bhowmik; Anand Kant Das; Bankanidhi Sahoo; Sudipta Maiti; Perunthiruthy K Madhu
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

3.  Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein.

Authors:  Subramaniam Boopathi; Ponmalai Kolandaivel
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

Review 4.  What amyloid ligands can tell us about molecular polymorphism and disease.

Authors:  Harry LeVine; Lary C Walker
Journal:  Neurobiol Aging       Date:  2016-03-24       Impact factor: 4.673

5.  Pulsed Hydrogen-Deuterium Exchange Reveals Altered Structures and Mechanisms in the Aggregation of Familial Alzheimer's Disease Mutants.

Authors:  Eva Illes-Toth; Georg Meisl; Don L Rempel; Tuomas P J Knowles; Michael L Gross
Journal:  ACS Chem Neurosci       Date:  2021-05-14       Impact factor: 5.780

6.  Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.

Authors:  Sathish Kumar; Oliver Wirths; Kathrin Stüber; Patrick Wunderlich; Philipp Koch; Sandra Theil; Nasrollah Rezaei-Ghaleh; Markus Zweckstetter; Thomas A Bayer; Oliver Brüstle; Dietmar R Thal; Jochen Walter
Journal:  Acta Neuropathol       Date:  2016-02-22       Impact factor: 17.088

7.  Atomistic investigation of an Iowa Amyloid-β trimer in aqueous solution.

Authors:  Son Tung Ngo; Huong Thi Thu Phung; Khanh B Vu; Van V Vu
Journal:  RSC Adv       Date:  2018-12-13       Impact factor: 3.361

8.  Molecular dynamics simulations of copper binding to amyloid-β Glu22 mutants.

Authors:  Shaun T Mutter; Matthew Turner; Robert J Deeth; James A Platts
Journal:  Heliyon       Date:  2019-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.